Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload
- 1 December 2007
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 31, S10-S15
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Early clinical impact of iron overload in stem cell transplantation. A prospective studyAnnals of Hematology, 2007
- Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantationBlood, 2007
- Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patientsBone Marrow Transplantation, 2006
- Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision MakingJournal of Clinical Oncology, 2005
- Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stressBone Marrow Transplantation, 2004
- Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosisBone Marrow Transplantation, 2004
- Guidelines for the diagnosis and therapy of adult myelodysplastic syndromesBritish Journal of Haematology, 2003
- Surcharge martiale et syndromes myélodysplasiques (SMD)Transfusion Clinique et Biologique, 2001
- Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patientsLeukemia Research, 2000
- Efficacy of Deferoxamine in Preventing Complications of Iron Overload in Patients with Thalassemia MajorNew England Journal of Medicine, 1994